JPMORGAN CHASE & CO - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 41 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q2 2021$4,000
-96.9%
4,000
-96.9%
0.00%
Q1 2021$130,000
-89.8%
128,000
-89.0%
0.00%
Q4 2020$1,272,000
-10.8%
1,167,000
-15.1%
0.00%
Q3 2020$1,426,000
-21.9%
1,375,000
-16.9%
0.00%
Q2 2020$1,826,000
-17.8%
1,655,000
-23.9%
0.00%
-100.0%
Q1 2020$2,222,000
-22.0%
2,176,000
-12.5%
0.00%0.0%
Q4 2019$2,848,000
+0.4%
2,487,0000.0%0.00%0.0%
Q3 2019$2,836,000
-59.5%
2,487,000
-57.7%
0.00%0.0%
Q2 2019$7,007,000
-43.7%
5,880,000
-36.1%
0.00%
-66.7%
Q1 2019$12,445,000
+52.9%
9,201,000
+21.8%
0.00%
+50.0%
Q4 2018$8,137,000
+1.0%
7,557,000
-1.3%
0.00%0.0%
Q3 2018$8,058,000
+18.3%
7,657,000
+10.2%
0.00%
+100.0%
Q2 2018$6,811,000
-6.7%
6,948,000
-5.6%
0.00%
-50.0%
Q1 2018$7,298,000
-39.4%
7,359,000
-35.5%
0.00%
-33.3%
Q4 2017$12,040,000
+14.5%
11,417,000
+17.1%
0.00%
+50.0%
Q3 2017$10,516,000
+5.9%
9,749,000
+4.1%
0.00%0.0%
Q2 2017$9,932,000
+10.2%
9,368,000
-0.0%
0.00%0.0%
Q1 2017$9,009,000
-7.0%
9,371,0000.0%0.00%0.0%
Q4 2016$9,682,000
+5.8%
9,371,000
-4.5%
0.00%0.0%
Q3 2016$9,154,000
-52.7%
9,812,000
-64.3%
0.00%
-60.0%
Q2 2016$19,370,000
-21.3%
27,523,000
+1.7%
0.01%
-16.7%
Q1 2016$24,625,000
-8.5%
27,053,000
+11.6%
0.01%
-14.3%
Q4 2015$26,902,00024,236,0000.01%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q4 2020
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 73,641,000$58,038,0004.94%
STEELHEAD PARTNERS LLC 52,496,000$62,306,0004.87%
SILVERBACK ASSET MANAGEMENT LLC 25,000,000$29,656,0004.56%
Castle Creek Arbitrage, LLC 10,734,000$12,733,0003.32%
TENOR CAPITAL MANAGEMENT Co., L.P. 40,132,000$47,726,0002.41%
Sonora Investment Management, LLC 17,232,000$20,380,0002.28%
TORONTO DOMINION BANK 1,000,002$5,947,335,0001.84%
TFG Asset Management GP Ltd 8,500,000$10,084,0001.46%
SYMPHONY ASSET MANAGEMENT LLC 5,000,000$5,925,0001.24%
SSI INVESTMENT MANAGEMENT LLC 13,441,000$15,893,0001.18%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders